Cargando…
Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials
BACKGROUND: While multiple randomized trials have evaluated the benefit of radiation therapy (RT) dose escalation and the use and prolongation of androgen deprivation therapy (ADT) in the treatment of prostate cancer, few studies have evaluated the relative benefit of either form of treatment intens...
Autores principales: | Jiang, Tommy, Markovic, Daniela, Patel, Jay, Juarez, Jesus E., Ma, Ting Martin, Shabsovich, David, Nickols, Nicholas G., Reiter, Robert E., Elashoff, David, Rettig, Matthew B., Zaorsky, Nicholas G., Spratt, Daniel E., Kishan, Amar U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018418/ https://www.ncbi.nlm.nih.gov/pubmed/34400799 http://dx.doi.org/10.1038/s41391-021-00432-2 |
Ejemplares similares
-
Androgen deprivation therapy in high risk prostate cancer
por: Van Dams, Ritchell, et al.
Publicado: (2019) -
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials
por: Ma, Ting Martin, et al.
Publicado: (2023) -
Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
por: Zaorsky, Nicholas G., et al.
Publicado: (2020) -
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
por: Kishan, Amar U., et al.
Publicado: (2022) -
Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19
por: O'Callaghan, M.E., et al.
Publicado: (2020)